London: The Cannabis and Psychedelics Investment Summit

Here are the speakers and the agenda

Speakers

Join our industry experts, entrepreneurs, and investors as they discuss the critical topics investors should consider.

Molly Maloof

Molly Maloof

Founder & CEO, Adamo Bioscience

Andy Goren, MD

Andy Goren, MD

Jupiter Wellness

Crispin Blunt

Crispin Blunt

Member of Parliament of the United Kingdom

Bruce Linton

Bruce Linton

Entrepreneur and Investor

Mikael Sodergren

Mikael Sodergren

Sapphire Clinics

Julia Germaine

Julia Germaine

Operating Partner, KindRun

Marco Hoffmann

Marco Hoffmann

Chief Executive Officer, SWISS Gate AG

David Bonnier

David Bonnier

Enexis AB

Kingsley Wilson

Kingsley Wilson

Partner, Chrystal Capital Partners

David Feldman

David Feldman

CEO & Co-Founder, Skip Intro

JJ McKay

JJ McKay

Founder / Publisher, The Fresh Toast

Rob Sechrist

Rob Sechrist

President, Pelorus Equity Group, Inc.

Kevin McGovern

Kevin McGovern

McGovern Capital

Tristan Gervais,

Tristan Gervais,

Head of Chrystal Capital Health & Wellness, Chrystal Capital Partners LLP

Saphira Galoob

Saphira Galoob

CEO, The Liaison Group

Agenda

9:00am-10:00am

Breakfast, Registration & Mingling

10:00am-10:10am

MC Opening Remarks​

10:10am-11:00am

An Overview of the Legal Cannabis and Psychedelic Industry​

11:00am-11:40am

U.S. Markets

11:40am-12:10pm

European Medicinal cannabis

12:10pm-12:50pm

Investor Pitch Session​​

12:50pm-2:00pm

Networking Lunch​

2:00pm-2:30pm

M&A and Capital Markets​

2:30pm-3:10pm

The Benefits of an Investment Fund in The Cannabis Industry​

3:10pm-3:30pm

Refreshment Break​

3:30pm-4:20pm

Investing In Psychedelic Medicine ​​

4:20pm-5:00pm

Investment 101 for Family Offices:

5:00pm-6:00pm

Cocktail Reception